Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Pharmacological Research|February 19, 2026
Selective PPAR δ Activation and Seladelpar Efficacy in Primary Biliary Cholangitis and beyondAlessio Gerussi, Matteo FornaiFrontiers in Pharmacology|November 19, 2024
JAK inhibitors: an evidence-based choice of the most appropriate moleculeLuca Antonioli, Alessandro Armuzzi, Massimo C Fantini, et al.Methods in Molecular Biology (Clifton, N.J.)|October 1, 2025
Enteric Glial Cell Culture to Mimic In Vivo Obesity and Neurodegenerative DisordersVanessa D'Antongiovanni, Clelia Di Salvo, Laura Benvenuti, et al.British Journal of Pharmacology|June 11, 2011
A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric 'purinome' conceptLuca Antonioli, Matteo Fornai, Rocchina Colucci, et al.International Journal of Molecular Sciences|June 16, 2019
Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory DiseasesCarolina Pellegrini, Matteo Fornai, Luca Antonioli, et al.Immunology Letters|April 28, 2018
Adenosine signaling and the immune system: When a lot could be too muchLuca Antonioli, Matteo Fornai, Corrado Blandizzi, et al.Expert Opinion on Therapeutic Targets|June 25, 2014
Adenosine pathway and cancer: where do we go from here?Luca Antonioli, György Haskó, Matteo Fornai, et al.Current Opinion in Pharmacology|July 14, 2023
Adenosine signaling as target in cardiovascular pharmacologyLuca Antonioli, Matteo Fornai, Carolina Pellegrini, et al.Acta Neuropathologica|May 26, 2018
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?Carolina Pellegrini, Luca Antonioli, Rocchina Colucci, et al.Frontiers in Immunology|February 10, 2017
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal InflammationCarolina Pellegrini, Luca Antonioli, Gloria Lopez-Castejon, et al.Pageof 13